Home Tags MRTX849

Tag: MRTX849

General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

Combination of Adagrasib and Pembrolizumab in First-Line Non-Small Cell Lung Cancer...

Editorial Team -
General images of ESMO 2019 Congress being held in Barcelona, Spain, September 27 - October 1, 2019. Courtesy European Society for Medical Oncology (ESMO). Used with Permission.

Adagrasib Shows Positive Results as Monotherapy and in Combination with Cetuximab...

Editorial Team -

Sotorasib Received Breakthrough Therapy in China

Danielle Garcia -
Physician consulting with a patients in hospital exam room.

Onvasertib: Confirmed Tumor Regression + Clinical Benefit in KRAS-Mutated mCRC

Peter Hofland -

LATEST NEWS